Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 4155 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
Read this article

 


    Article Cited by others

ORIGINAL ARTICLE

A comparative study of oxidative stress and interrelationship of important antioxidants in haloperidol and olanzapine treated patients suffering from schizophrenia

Singh Om Prakash, Chakraborty Indranil, Dasgupta Anindya, Datta Subinay

Year : 2008| Volume: 50| Issue : 3 | Page no: 171-177

   This article has been cited by
 
1 A comparison of dissolving microneedles and transdermal film with solid microneedles for iloperidone in vivo: a proof of concept
Rupali S. Bhadale, Vaishali Y. Londhe
Naunyn-Schmiedeberg's Archives of Pharmacology. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 Present and future antipsychotic drugs: a systematic review of the putative mechanisms of action for efficacy and a critical appraisal under a translational perspective
Andrea de Bartolomeis, Annarita Barone, Veronica Begni, Marco Andrea Riva
Pharmacological Research. 2022; : 106078
[Pubmed]  [Google Scholar] [DOI]
3 Resveratrol prevents haloperidol-induced mitochondria dysfunction through the induction of autophagy in SH-SY5Y cells
Minmin Hu, Ruiqi Wang, Xi Chen, Mingxuan Zheng, Peng Zheng, Zehra Boz, Renxian Tang, Kuiyang Zheng, Yinghua Yu, Xu-Feng Huang
NeuroToxicology. 2021; 87: 231
[Pubmed]  [Google Scholar] [DOI]
4 Haloperidol elicits oxidative damage in the brain of rats submitted to the ketamine-induced model of schizophrenia
Samira S. Valvassori, José H. Cararo, Samira Menegas, Taise Possamai-Della, Jorge M. Aguiar-Geraldo, Simone Lespinasse Araujo, Gustavo Antunes Mastella, Joăo Quevedo, Alexandra I. Zugno
Brain Research Bulletin. 2021; 170: 246
[Pubmed]  [Google Scholar] [DOI]
5 Understanding the effects of Moringa oleifera in chronic unpredictable stressed zebrafish using metabolomics analysis
Muhammad Shazly Rosdy, Mohd Salleh Rofiee, Nurdiana Samsulrizal, Mohd Zaki Salleh, Lay Kek Teh
Journal of Ethnopharmacology. 2021; 278: 114290
[Pubmed]  [Google Scholar] [DOI]
6 Oxidative Stress-Related Mechanisms in Schizophrenia Pathogenesis and New Treatment Perspectives
Evgeny A. Ermakov, Elena M. Dmitrieva, Daria A. Parshukova, Daria V. Kazantseva, Alisa R. Vasilieva, Liudmila P. Smirnova, Karolina Szewczyk-Golec
Oxidative Medicine and Cellular Longevity. 2021; 2021: 1
[Pubmed]  [Google Scholar] [DOI]
7 Do Immune Dysregulations and Oxidative Damage Drive Mood and Psychotic Disorders?
Manuel Morrens, Violette Coppens, Sebastian Walther
Neuropsychobiology. 2020; 79(4-5): 251
[Pubmed]  [Google Scholar] [DOI]
8 Peripheral non-enzymatic antioxidants in patients with schizophrenia: a case-control study
Zhe Lu, Tianyang Wen, Yingtan Wang, Weijing Kan, Guanglei Xun
BMC Psychiatry. 2020; 20(1)
[Pubmed]  [Google Scholar] [DOI]
9 Antioxidant Potential of Psychotropic Drugs: From Clinical Evidence to In Vitro and In Vivo Assessment and toward a New Challenge for in Silico Molecular Design
Giovanni Ribaudo, Marco Bortoli, Chiara Pavan, Giuseppe Zagotto, Laura Orian
Antioxidants. 2020; 9(8): 714
[Pubmed]  [Google Scholar] [DOI]
10 Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia
Giuseppe Caruso, Margherita Grasso, Annamaria Fidilio, Fabio Tascedda, Filippo Drago, Filippo Caraci
Pharmaceuticals. 2020; 13(12): 457
[Pubmed]  [Google Scholar] [DOI]
11 Modulations in the ATPases during ketamine-induced schizophrenia and regulatory effect of “3-(3, 4-dimethoxy phenyl) -1- (4-methoxyphenyl) prop-2-en-1-one”: anin vivoandin silicostudies
Chintha Venkataramaiah
Journal of Receptors and Signal Transduction. 2020; 40(2): 148
[Pubmed]  [Google Scholar] [DOI]
12 Increased mitochondrial and cytosolic antioxidant enzymes in manic episodes
E. Kahyaci Kiliç, R. Köse Çinar, Y. Görgülü, M.B. Sönmez
The European Journal of Psychiatry. 2020; 34(4): 181
[Pubmed]  [Google Scholar] [DOI]
13 Oxidation-reduction mechanisms in psychiatric disorders: A novel target for pharmacological intervention
Andrea Carlo Rossetti, Maria Serena Paladini, Marco Andrea Riva, Raffaella Molteni
Pharmacology & Therapeutics. 2020; 210: 107520
[Pubmed]  [Google Scholar] [DOI]
14 Role of membrane cholesterol and lipid peroxidation in regulating the Na+/K+-ATPase activity in schizophrenia
Suparna Roy, Anindya Dasgupta, Ushasi Banerjee, Piali Chowdhury, Ashis Mukhopadhyay, Gautam Saha, Omprakash Singh
Indian Journal of Psychiatry. 2016; 58(3): 317
[Pubmed]  [Google Scholar] [DOI]
15 Active ribosomal genes, translational homeostasis and oxidative stress in the pathogenesis of schizophrenia and autism
Lev N. Porokhovnik,Vladimir P. Passekov,Nataliya L. Gorbachevskaya,Alexander B. Sorokin,Nataliya N. Veiko,Nataliya A. Lyapunova
Psychiatric Genetics. 2015; 25(2): 79
[Pubmed]  [Google Scholar] [DOI]
16 Increased oxidative stress and oxidative DNA damage in non-remission schizophrenia patients
U. Sertan Copoglu, Osman Virit, M. Hanifi Kokacya, Mustafa Orkmez, Feridun Bulbul, A. Binnur Erbagci, Murat Semiz, Gokay Alpak, Ahmet Unal, Mustafa Ari, Haluk A. Savas
Psychiatry Research. 2015; 229(1-2): 200
[Pubmed]  [Google Scholar] [DOI]
17 Refining and integrating schizophrenia pathophysiology – Relevance of the allostatic load concept
Blazej Misiak,Dorota Frydecka,Marcin Zawadzki,Maja Krefft,Andrzej Kiejna
Neuroscience & Biobehavioral Reviews. 2014;
[Pubmed]  [Google Scholar] [DOI]
18 Mitochondrial dysfunction in schizophrenia: Pathways, mechanisms and implications
Ashwini Rajasekaran,Ganesan Venkatasubramanian,Michael Berk,Monojit Debnath
Neuroscience & Biobehavioral Reviews. 2014;
[Pubmed]  [Google Scholar] [DOI]
19 Oxidative stress, rRNA genes, and antioxidant enzymes in pathogenesis of schizophrenia and autism: Modeling and clinical recommendations
L. N. Porokhovnik,V. P. Pasekov,N. A. Yegolina,T. G. Tzvetkova,N. V. Kosyakova,N. L. Gorbachevskaya,N. K. Sukhotina,G. V. Kozlovskaya,A. B. Sorokin,N. Yu. Korovina,N. A. Lyapunova
Biology Bulletin Reviews. 2014; 4(5): 363
[Pubmed]  [Google Scholar] [DOI]
20 Assessment of novel iloperidone- and idebenone-loaded nanostructured lipid carriers: brain targeting efficiency and neuroprotective potential
Leenata Mandpe,Abhay Kyadarkunte,Varsha Pokharkar
Therapeutic Delivery. 2013; 4(11): 1365
[Pubmed]  [Google Scholar] [DOI]
21 Meta-Analysis of Oxidative Stress in Schizophrenia
Joshua Flatow,Peter Buckley,Brian J. Miller
Biological Psychiatry. 2013; 74(6): 400
[Pubmed]  [Google Scholar] [DOI]
22 Oxidative stress markers in schizophrenic patients
H. Mabrouk,I. Houas,H. Mechria,A. Mechri,W. Douki,L. Gaha,M.F. Najjar
Immuno-analyse & Biologie Spécialisée. 2013; 28(1): 51
[Pubmed]  [Google Scholar] [DOI]
23 Reduced total antioxidant level and increased oxidative stress in patients with deficit schizophrenia: A preliminary study
Yakup Albayrak,Cüneyt Ünsal,Murat Beyazyüz,Ahmet Ünal,Murat Kuloglu
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2013; 45: 144
[Pubmed]  [Google Scholar] [DOI]
24 Viral infection, inflammation and schizophrenia
Rachel E. Kneeland, S. Hossein Fatemi
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2012;
[HTML Full text]  [Google Scholar] [DOI]
25 The Relationship Between Serum Uric Acid Concentration and Metabolic Syndrome in Patients With Schizophrenia or Schizoaffective Disorder
Chih-Chiang Chiu,Chun-Hsin Chen,Ming-Chyi Huang,Po-Yu Chen,Chang-Jer Tsai,Mong-Liang Lu
Journal of Clinical Psychopharmacology. 2012; 32(5): 585
[Pubmed]  [Google Scholar] [DOI]
26 Role of antioxidants in generalised anxiety disorder and depression
Medhavi Gautam, Mukta Agrawal, Manaswi Gautam, Praveen Sharma, AnitaSharma Gautam, Shiv Gautam
Indian Journal of Psychiatry. 2012; 54(3): 244
[Pubmed]  [Google Scholar] [DOI]
27 Antipsychotic Induced Alteration of Growth and Proteome of Rat Neural Stem Cells
Eakhlas Uddin Ahmed, Selina Ahmed, Wataru Ukai, Izuru Matsumoto, Andrew Kemp, Iain S. McGregor, Mohammed Abul Kashem
Neurochemical Research. 2012;
[HTML Full text]  [Google Scholar] [DOI]
28 Increased Oxidant Stress and Inflammation in Patients with Chronic Schizophrenia
Aysenur Yegin,Nurullah Ay,Ozgur Aydin,Nedim Yargici,Esin Eren,Necat Yilmaz
International Journal of Clinical Medicine. 2012; 03(05): 368
[Pubmed]  [Google Scholar] [DOI]
29 Increased breath ethane and pentane concentrations in currently unmedicated patients with schizophrenia
Brian M. Ross,Sandeep Shah,Malcolm Peet
Open Journal of Psychiatry. 2011; 01(01): 1
[Pubmed]  [Google Scholar] [DOI]
30 MK-801 alters Na+, K+-ATPase activity and oxidative status in zebrafish brain: reversal by antipsychotic drugs
Kelly Juliana Seibt, Renata Luz Oliveira, Denis Broock Rosemberg, Luiz Eduardo Baggio Savio, Emilene B. S. Scherer, Felipe Schmitz, Angela T. S. Wyse, Carla Denise Bonan
Journal of Neural Transmission. 2011;
[HTML Full text]  [Google Scholar] [DOI]
31 Oxidative stress in schizophrenia: An integrated approach
Byron K.Y. Bitanihirwe, Tsung-Ung W. Woo
Neuroscience & Biobehavioral Reviews. 2011; 35(3): 878
[HTML Full text]  [Google Scholar] [DOI]
32 Protective effects of atypical antipsychotic drugs against MPP+-induced oxidative stress in PC12 cells
Sung Woo Park, Chan Hong Lee, Jung Goo Lee, Luck Woo Kim, Bae Sub Shin, Bong Ju Lee, Young Hoon Kim
Neuroscience Research. 2011; 69(4): 283
[HTML Full text]  [Google Scholar] [DOI]
33 Alteration of the pro-oxidant xanthine oxidase (XO) in the thalamus and occipital cortex of patients with schizophrenia
Tanja Maria Michel, Abigail Jane Sheldrick, Sybille Camara, Edna Grünblatt, Frank Schneider, Peter Riederer
World Journal of Biological Psychiatry. 2011; 12(8): 588
[HTML Full text]  [Google Scholar] [DOI]
34 Sulforaphane protects SK-N-SH cells against antipsychotic-induced oxidative stress : Antipsychotic sulforaphane protection
Miquel Bernardo, Amalia Lafuente, Sergi Mas, Patricia Gassó, Gemma Trias
Fundamental and Clinical Pharmacology. 2011; : no
[HTML Full text]  [Google Scholar] [DOI]
35 Increased breath ethane levels in medicated patients with schizophrenia and bipolar disorder are unrelated to erythrocyte omega-3 fatty acid abundance
Brian M. Ross, Ross Maxwell, Iain Glen
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2011; 35(2): 446
[HTML Full text]  [Google Scholar] [DOI]
36 Oxidative stress, antioxidant defenses, and schizophrenia : Oxidative stress, antioxidant defenses, and schizophrenia
Wei-Yi Ong, Kang Sim, Akhlaq A. Farooqui
Asia-Pacific Psychiatry. 2010; 2(4): 180
[HTML Full text]  [Google Scholar] [DOI]
37 Biological investigations in Indian psychiatry
RishikeshV Behere, NarenP Rao, Ganesan Venkatasubramanian
Indian Journal of Psychiatry. 2010; 52(7): 136
[Pubmed]  [Google Scholar] [DOI]
38 An overview of Indian research in schizophrenia
Parmanand Kulhara, Ruchita Shah, KR Aarya
Indian Journal of Psychiatry. 2010; 52(7): 159
[Pubmed]  [Google Scholar] [DOI]
39 Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics
Manuela Padurariu, Alin Ciobica, Irina Dobrin, Cristinel Stefanescu
Neuroscience Letters. 2010; 479(3): 317
[HTML Full text]  [Google Scholar] [DOI]
40 Evaluation of carotenoid level in schizophrenic patients using non-invasive measurement
Tze Jen Chow,Han Chern Loh,Shiau Foon Tee,Pek Yee Tang
Asian Journal of Psychiatry. 2010; 3(4): 190
[Pubmed]  [Google Scholar] [DOI]
41 Correlation between lipid peroxidation-induced TBARS level and disease severity in obsessive–compulsive disorder
Sutirtha Chakraborty,Om Prakash Singh,Anindya Dasgupta,Nikhiles Mandal,Harendra Nath Das
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2009; 33(2): 363
[Pubmed]  [Google Scholar] [DOI]